
|Articles|July 23, 2004
Agents for stress incontinence, overactive bladder show positive results
Two investigational drugs-one for stress incontinence and one for overactive bladder-showed positive results in separate presentations at the International Consultation on Incontinence in Monte Carlo, Monaco.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Laura Bukavina, MD, and Gabriela Díaz, MD, on the rise of young-onset bladder cancer
3
Individualizing androgen pathway therapy in mCSPC
4
BOND-003 Cohort C: Efficacy Results
5








